Levamizole enhances immune responsiveness to intra-dermal and intra-muscular hepatitis B vaccination in chronic hemodialysis patients

BACKGROUND: Hemodialysis patient are at high risk for hepatitis B virus (HBV) infection. Although preventive vaccination is done routinely, the response to vaccination is low in this patient population. The aim of this study was to evaluate the effect of Levamizol, an enhancer of the immune responsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Argani, Hassan, Akhtarishojaie, Ebrahim
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1540413/
https://www.ncbi.nlm.nih.gov/pubmed/16734912
http://dx.doi.org/10.1186/1476-8518-4-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1540413/
https://www.ncbi.nlm.nih.gov/pubmed/16734912
http://dx.doi.org/10.1186/1476-8518-4-3

Ejemplares similares